Join the 155,000+ IMP followers

www.medical-devices.tech

AI Lung Cancer Screening Algorithms Trained on German Clinical Data

Siemens Healthineers and Sana Kliniken partner to train and clinically evaluate AI diagnostic software using anonymised German hospital data.

  www.siemens-healthineers.com
AI Lung Cancer Screening Algorithms Trained on German Clinical Data

Siemens Healthineers and Sana Kliniken have agreed to collaborate on the development of AI-powered software for diagnostics and therapy planning, starting with algorithms for lung cancer screening. The partnership combines curated clinical data from German hospitals and radiology practices with Siemens Healthineers' medical imaging and AI development, targeting radiology, oncology and hospital clinical workflows.

Partners and Their Roles
Sana Data Solutions GmbH, a subsidiary of Sana Kliniken AG, will provide curated health data from Germany in a secure, controlled data environment. Sana Kliniken operates 50 hospitals and 66 medical care centre companies across the German-speaking region. Siemens Healthineers will use the anonymised data as one component in training AI-powered tools and developing the corresponding software products.

The Data Challenge in Medical AI Development
AI models for diagnostic imaging require large, well-annotated datasets that reflect the patient populations and clinical practice in which they will be used. According to the partners, projects of this kind have often relied on data from outside Europe. Access to representative European data, combined with a framework for clinical testing, is therefore a key factor in developing tools that perform reliably in European care settings and meet regulatory requirements.

Technical Approach and Data Scope
The first joint project will develop AI algorithms for lung cancer screening. Sana Kliniken and its affiliated radiology facilities will provide anonymised clinical and pathological datasets, including images, annotations and radiology reports. In later stages, the data will also include patient context, results and examination sequences, allowing models to relate imaging findings to diagnostic outcomes. Comprehensive security concepts are intended to ensure compliance with data protection and data security standards.

Clinical Evaluation and Deployment
In a second step, the partners plan to evaluate the resulting software in day-to-day clinical settings at Sana Kliniken hospitals and affiliated radiology practices. This creates a real-world testing environment in which medically relevant software can be developed and clinically evaluated more quickly while meeting regulatory requirements. Both companies expect earlier testing of AI tools and workflows under real conditions, faster and improved diagnostic capabilities and more personalised treatment recommendations.

Stefan Schaller, Head of the Central and Western Europe region at Siemens Healthineers, said: "If data-driven innovation is to have an impact in healthcare, it needs to be close to care delivery—and it needs clear rules."

Michael Hübner, Managing Director of Sana Data Solutions GmbH, said: "AI-powered analysis of the data enables us to make complex medical relationships visible—with a depth and speed that would not be achievable through manual analysis alone."

Expected Impact on European Data Sovereignty
By developing and validating AI models on German clinical data, the partnership aims to strengthen Germany's position as an innovation hub and support European data sovereignty in healthcare. The approach is relevant as medical AI software in Europe is regulated as a medical device and as a high-risk application under the EU AI Act, making documented data provenance and clinical evaluation increasingly important.

Edited by Natania Lyngdoh, Induportals editor, with AI assistance.

www.siemens-healthineers.com

  Ask For More Information…

LinkedIn
Pinterest

Join the 155,000+ IMP followers

International